News

June 20, 2011 — Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for heart-type fatty acid binding protein (H-FABP) to improve the...
June 17, 2011 – The new Pathfast cTnI-II (cardiac troponin I) test from Mitsubishi Chemical Medience Corporation has been granted 510(k) premarketing notification clearance by the U.S. Food and Drug...
June 3, 2011 - Research presented at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical...
June 3, 2011 – European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet reactivity test to identify patients who are poor-responders to antiplatelet...

March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows real time transmission of diagnostic test results generated directly from...

March 25, 2011 – A new galectin-3 test, recently cleared by the U.S. Food and Drug Administration (FDA) to help assess the prognosis of patients with chronic heart failure, is now offered by...

March 10, 2011 – New guidelines have been published in The Annals of Thoracic Surgery that include point-of-care testing for platelet reactivity as a new recommendation for...

February 25, 2011 – A diagnostic test used to help treat patients with high cholesterol received CE mark approval in Europe. The KIF6 genotyping assay, from Abbott, detects a genetic marker that...

February 7, 2011 – Final testing for a point-of-care blood analyzer will begin at four hospitals in North America. The QL Care (QLCA) analyzer, by CardioGenics, tests for troponin-I levels, and...

February 3, 2011 – Behrman Capital, a private equity investment firm based in New York and San Francisco, has acquired Atherotech, a cardiometabolic testing services provider. Atherotech offers...

November 17, 2010 - Results from the GRAVITAS Trial found that doubling the maintenance dose of clopidogrel (Plavix) did not reduce the risk of further ischemic events after percutaneous coronary...

October 28, 2010 - The first patent related to specific human blood protein variant biomarkers related to cardiovascular disease has been issued. The United States Patents and Trademark Office has...

July 23, 2010 – For patients suffering from a heart attack, every minute counts, yet the average time from start of chest pain to receiving emergency room (ER) medical attention is 3.2 hours. The...

July 23, 2010 - At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus (HIV), two international meetings of HIV/AIDS...

July 22, 2010 – Accumetrics Inc., Daiichi Sankyo Inc., and Eli Lilly and Co. recently announced that they have entered into a strategic collaboration in the United States to raise awareness about...

June 2, 2010 – A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was released this week. The system detect blood clotting time for patients stabilized on...

May 14, 2010 — A partnership to develop cardiovascular genomic diagnostic testing devices has been signed between GE Healthcare and CardioDx.

March 31. 2010 – The FDA granted Clinical Laboratory Improvement Amendments (CLIA)-waived status to expand the use of a point-of-care anti-coagulation monitor to a broader range of clinical...

March 24, 2010 — Several genes are associated with heart disease, stroke, and high blood pressure, and can determine whether people may have predisposition to these conditions, according to...

March 9, 2010 — An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a...